Pulse Biosciences, Inc. Stock Analysis & AI Score
Pulse Biosciences, Inc. (PLSE) has an ST Score of 42.1 (C), driven by its Momentum (A-) and held back by its Profitability (F). Analysts rate it Buy with a $50.20 price target (-3.1% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Pulse Biosciences, Inc. (PLSE) has an ST Score of 42.1 (C), driven by its Momentum (A-) and held back by its Profitability (F). Analysts rate it Buy with a $50.20 price target (-3.1% downside).
- Strongest
- MomentumA-
- Weakest
- ProfitabilityF
All factor grades
- MomentumA-
- Financial StrengthB+
- ForecastC+
- ValuationC
- GrowthD+
- ProfitabilityF
- Piotroski3/9
Contact
PLSE stock: frequently asked questions
What is PLSE's ST Score?
Pulse Biosciences, Inc. (PLSE) has an ST Score of 42.1 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is PLSE a buy, hold, or sell?
Analysts rate PLSE a Buy, with a price target of $50.20 (-3.1% vs the current price). Our ST Score grades it C (42.1/100). The ST Score is a data-driven signal, not a recommendation.
What are PLSE's factor grades?
Valuation C, Profitability F, Financial Strength B+, Momentum A-, Growth D+, Forecast C+.
What is PLSE's valuation grade?
Pulse Biosciences, Inc. (PLSE) earns a valuation grade of C, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is PLSE's growth grade?
Pulse Biosciences, Inc. (PLSE) earns a growth grade of D+, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is PLSE's profitability grade?
Pulse Biosciences, Inc. (PLSE) earns a profitability grade of F, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is PLSE's financial strength grade?
Pulse Biosciences, Inc. (PLSE) earns a financial strength grade of B+, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for PLSE?
The average analyst price target for Pulse Biosciences, Inc. (PLSE) is $50.20 from 5 analysts, which is -3.1% versus the recent price of $51.83.
What is PLSE's Piotroski score?
Pulse Biosciences, Inc. (PLSE) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.